赛伦生物: 赛伦生物：公司章程（2025年7月）

Core Points - The company, Shanghai Serum Bio-Technology Co., Ltd., was established as a joint-stock company in accordance with the Company Law and other relevant regulations [1][2] - The company was approved for public offering of 27.06 million shares on January 25, 2022, and listed on the Shanghai Stock Exchange on March 11, 2022, under the stock code 688163 [2][3] - The registered capital of the company is RMB 108.22 million [2] - The company aims to adopt advanced and practical technologies and scientific management methods to enhance economic efficiency and provide satisfactory returns to investors [3][4] Company Structure - The company is a permanent joint-stock company with a legal representative being the chairman [2][3] - The company has established a Communist Party organization to conduct party activities [3][4] Business Scope - The company is engaged in the production and import/export of pharmaceuticals and medical devices, as well as internet information services related to pharmaceuticals and medical devices [4][5] Share Issuance - The company's shares are issued in the form of stocks, with each share having a par value of RMB 1 [6][7] - The total number of shares issued at the establishment of the company was 60 million, and the current total number of issued shares is 108.22 million [6][7] Shareholder Rights and Responsibilities - Shareholders have rights to dividends, voting, and other benefits proportional to their shareholdings [11][12] - Shareholders are obligated to comply with laws and the company's articles of association, and they cannot withdraw their capital except as legally permitted [16][17] Governance and Meetings - The company holds annual and extraordinary shareholder meetings, with specific procedures for calling and conducting these meetings [48][49] - The board of directors is responsible for convening shareholder meetings and must ensure compliance with legal and regulatory requirements [52][53] Financial Transactions - Significant transactions, including guarantees and financial assistance, require shareholder approval if they exceed certain thresholds [46][47] - The company must disclose relevant financial information in its annual and semi-annual reports [20][21]